[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Professional Survey Report 2018

January 2018 | 107 pages | ID: GFDAF91C4E3EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • Astellas Pharmaceuticals
  • Actavis
  • Pfizer
  • GlaxoSmithKline
  • Salix Pharmaceuticals Ltd
  • AstraZenenca
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Preface
  • Eluxadoline
  • Alosetron
  • Rifaximin
  • Loperamide
  • Diphenoxylate + Atropine
  • Dicyclomine and Hyoscyamine
By Application, the market can be split into
  • Hospitals
  • Clinics
  • Others
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS

1.1 Definition and Specifications of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
  1.1.1 Definition of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
  1.1.2 Specifications of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.2 Classification of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
  1.2.1 Preface
  1.2.2 Eluxadoline
  1.2.3 Alosetron
  1.2.4 Rifaximin
  1.2.5 Loperamide
  1.2.6 Diphenoxylate + Atropine
  1.2.7 Dicyclomine and Hyoscyamine
1.3 Applications of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
2.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
2.4 Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS

3.1 Capacity and Commercial Production Date of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2016

4 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price
  4.4.2 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Analysis (Company Segment)

5 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
  5.1.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
  5.1.2 North America 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Analysis
  5.1.4 North America 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Analysis
5.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
  5.2.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
  5.2.2 China 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Analysis
  5.2.4 China 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Analysis
5.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
  5.3.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
  5.3.2 Europe 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Analysis
  5.3.4 Europe 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Analysis
5.4 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
  5.4.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Analysis
5.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
  5.5.1 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
  5.5.2 Japan 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Analysis
  5.5.4 Japan 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Analysis
5.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
  5.6.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
  5.6.2 India 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Analysis
  5.6.4 India 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Analysis

6 GLOBAL 2012-2017E IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
6.2 Different Types of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Interview Price Analysis
6.3 Different Types of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Driving Factors Analysis
  6.3.1 Preface of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Driving Factor Analysis
  6.3.2 Eluxadoline of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Driving Factor Analysis
  6.3.3 Alosetron of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Driving Factor Analysis
  6.3.4 Rifaximin of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Driving Factor Analysis
  6.3.5 Loperamide of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Driving Factor Analysis
  6.3.6 Diphenoxylate + Atropine of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Driving Factor Analysis
  6.3.7 Dicyclomine and Hyoscyamine of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Application
7.2 Different Application of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Interview Price Analysis
7.3 Different Application of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Driving Factors Analysis
  7.3.1 Hospitals of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Driving Factor Analysis
  7.3.2 Clinics of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Driving Factor Analysis
  7.3.3 Others of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS

8.1 Astellas Pharmaceuticals
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Astellas Pharmaceuticals 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Astellas Pharmaceuticals 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution Analysis
8.2 Actavis
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Actavis 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Actavis 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution Analysis
8.3 Pfizer
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Pfizer 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Pfizer 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution Analysis
8.4 GlaxoSmithKline
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 GlaxoSmithKline 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 GlaxoSmithKline 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution Analysis
8.5 Salix Pharmaceuticals Ltd
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Salix Pharmaceuticals Ltd 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Salix Pharmaceuticals Ltd 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution Analysis
8.6 AstraZenenca
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 AstraZenenca 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 AstraZenenca 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MARKET

9.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Forecast
9.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast
  9.2.2 China 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast
  9.2.6 India 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast
9.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trend (Product Type)
9.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trend (Application)

10 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MARKETING TYPE ANALYSIS

10.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Regional Marketing Type Analysis
10.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region
10.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table Product Specifications of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table Classification of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Global Production Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2016
Figure Preface Picture
Table Major Manufacturers of Preface
Figure Eluxadoline Picture
Table Major Manufacturers of Eluxadoline
Figure Alosetron Picture
Table Major Manufacturers of Alosetron
Figure Rifaximin Picture
Table Major Manufacturers of Rifaximin
Figure Loperamide Picture
Table Major Manufacturers of Loperamide
Figure Diphenoxylate + Atropine Picture
Table Major Manufacturers of Diphenoxylate + Atropine
Figure Dicyclomine and Hyoscyamine Picture
Table Major Manufacturers of Dicyclomine and Hyoscyamine
Table Applications of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Global Consumption Volume Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application in 2016
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Clinics Examples
Table Major Consumers in Clinics
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Regions
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2012-2022)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2012-2022)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2012-2022)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2012-2022)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2012-2022)
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in 2016
Figure Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table Capacity and Commercial Production Date of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 2012-2017
Figure Global 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity and Growth Rate
Table 2016 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate
Table 2016 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) List (Company Segment)
Table 2012-2017E Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price (USD/Unit)
Table 2016 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 2012-2017E
Figure North America 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price (USD/Unit)
Figure North America 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 2012-2017E
Figure China 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price (USD/Unit)
Figure China 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 2012-2017E
Figure Europe 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price (USD/Unit)
Figure Europe 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 2012-2017E
Figure Japan 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price (USD/Unit)
Figure Japan 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 2012-2017E
Figure India 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price (USD/Unit)
Figure India 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share
Table Global 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Type
Table Different Types Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Interview Price
Table Global 2012-2017E Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Application
Table Different Application Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Interview Price
Table Astellas Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution
Table Actavis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2015 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution
Table Salix Pharmaceuticals Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2016 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution
Table AstraZenenca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Region Distribution
Figure Global 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type 2017-2022
Table Global Consumption Volume (K Units) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region

More Publications

Need Help?

Ask a Question

Market Reports

All Categories